69 peptides · free, no signup

Peptide reference library.

The studied range, how often, half-life and evidence for each peptide, by goal. Every page adds how it works, safety notes and stacks, and a reconstitution example where one applies. A research range, never a dose for you.

By area

Where each peptide works.

Pick an area to see the peptides used for it. An area lights for what a peptide is used for and what people report, with the evidence beside it. It isn’t a promise that it works there.

A body with Appetite & metabolism lit

Appetite & metabolism

25 peptides · Appetite, weight, body fat, blood sugar, insulin, liver fat

  • Cagrilintide●●●

    In people. On its own in REDEFINE 1, it averaged 11.8% weight loss at 68 weeks for people who stayed on it.

  • CagriSema●●●

    In people. In its main trial people lost about 20% of body weight on average at 68 weeks, more than on semaglutide alone.

  • Dulaglutide●●●

    In people. In its 36-week trial it lowered HbA1c by 1.8 points and weight by 4.6 kg on average.

  • HGH●●●

    In people. In healthy adults, trials show about 2 kg of fat swapped for lean mass, with no strength gain and more side effects.

  • Liraglutide●●●

    In people. In the main trial, about two in three people lost at least 5% within a year on this dose.

  • Mazdutide●●●

    In people. In the phase 3 GLORY-1 trial, people lost about 11% to 14% of their body weight at 48 weeks.

  • Orforglipron●●●

    In people. Its top dose averaged about 11% weight loss at 72 weeks in its main trial.

  • Retatrutide●●●

    In people. Its top dose averaged about 25–28% weight loss at 80 weeks in phase 3.

  • Semaglutide●●●

    In people. About 15% average weight loss at 68 weeks in its main trial.

  • Semaglutide (oral)●●●

    In people. Used for type 2 diabetes, and as Wegovy tablets for weight management.

  • Survodutide●●●

    In people. Average weight loss at 76 weeks was 12–13% counting everyone and up to 16.6% for people who stayed on it.

  • Tesamorelin●●●

    In people. In two phase 3 trials it cut visceral fat about 15% in 26 weeks.

  • Tirzepatide●●●

    In people. In a head-to-head trial it produced more weight loss than semaglutide (20.2% vs 13.7% at 72 weeks).

  • AOD-9604●●●

    In people. AOD-9604 showed modest weight loss in one 12-week trial, but a larger 24-week trial failed and obesity development stopped in 2007.

  • CJC-1295 no DAC●●●

    Reported by users. More lean mass and modest fat loss, with sleep strong and consistent.

  • CJC-1295 with DAC●●●

    Reported by users. Commonly reported in this window: measurable fat loss and lean gains.

  • Fragment 176-191●●●

    In animals. It targets fat cells: in rodents it boosted fat breakdown without affecting blood sugar or IGF-1.

  • GHRP-6●●●

    In animals. Significantly increases appetite (shown in animals and widely reported by users) — useful for those seeking to bulk.

  • Ipamorelin●●●

    Reported by users. Some report measurable fat loss and easier joints.

  • Oxytocin●●●

    In people. Single nasal doses cut food intake at a test meal and blunted stress responses in small studies, though an 8-week trial produced no weight loss.

  • Pemvidutide●●●

    In people. In a 48-week phase 2 obesity trial, average weight loss reached 15.6% on the top dose.

  • 5-Amino-1MQ●●●

    In animals. In obese mice it cut body weight and fat without reducing food intake.

  • Humanin●●●

    In animals. Its work is background cell protection and better insulin sensitivity, seen so far only in cells and rodents.

  • MOTS-c●●●

    In animals. In mice it activates AMPK, the pathway exercise triggers, improving insulin sensitivity and exercise capacity.

  • SLU-PP-332●●●

    In animals. In obese mice it raised energy expenditure and fat burning and cut fat gain without changing what they ate.

Healing & recovery13

  • Ac-SDKPTB-500 Fragment · TB-4 Frag · Goralatide · Thymosin Beta-4 (1-4)Studied range: 250–750 mcgHow often: EODHalf-life ~4.5 min●●●
  • AOD-9604Anti-Obesity Drug 9604 · HGH Fragment 177-191Studied range: 250–300 mcgHow often: DailyHalf-life ~30 min●●●
  • ARA-290Cibinetide · ARA290 · pHBSP · Helix B surface peptide · HBSPStudied range: 1–4 mgHow often: DailyHalf-life ~20 minutes●●●
  • BPC-157Body Protection Compound 157 · BPC157Studied range: 200–500 mcgHow often: 1–2× dailyHalf-life ~4–6 hours●●●
  • CartalaxAED peptide · Ala-Glu-Asp · KartalaxStudied range: No reference doseHow often: DailyHalf-life: no figure●●●
  • GHK-CuCopper Peptide · GHK-Copper · Tripeptide-1Studied range: 1–2 mgHow often: DailyHalf-life: no figure●●●
  • KPVLys-Pro-Val · α-MSH tripeptideStudied range: 100–300 mcgHow often: DailyHalf-life: no figure●●●
  • LarazotideAT-1001 · Larazotide AcetateStudied range: 0.5–1 mgHow often: 3× dailyHalf-life: no figure●●●
  • LL-37Cathelicidin · hCAP-18 · CAP-18Studied range: 100–300 mcgHow often: DailyHalf-life: no figure●●●
  • TB-500Thymosin Beta-4 Fragment · TB4Studied range: 1–2.5 mgHow often: 2× weeklyHalf-life ~0.5–2 hours●●●
  • Thymosin Alpha-1Tα1 · Thymalfasin · ZadaxinStudied range: 1–1.6 mgHow often: 2× weeklyHalf-life ~2 hours●●●
  • Thymosin Beta-4Tβ4 · Full TB4Studied range: 2–2.5 mgHow often: WeeklyHalf-life ~0.5–2 hours●●●
  • VIPVasoactive Intestinal Peptide · VIP neuropeptideStudied range: 50 mcgHow often: 2× dailyHalf-life ~2 min IV●●●

Growth hormone14

  • CJC-1295 no DACModified GRF 1-29 · Mod GRF 1-29 · CJC-1295 without DACStudied range: 100–200 mcgHow often: 2–3× dailyHalf-life ~30 min●●●
  • CJC-1295 with DACCJC-1295 DAC · DAC:GRFStudied range: 1–2 mgHow often: WeeklyHalf-life ~6–8 days●●●
  • Follistatin-344Follistatin · FST-344 · FS-344 · Follistatin 344Studied range: 100–200 mcgHow often: DailyHalf-life: no figure●●●
  • Fragment 176-191HGH Fragment 176-191 · HGH Frag · AOD FragmentStudied range: 250–500 mcgHow often: DailyHalf-life ~30 min●●●
  • GHRP-2Growth Hormone Releasing Peptide-2 · PralmorelinStudied range: 100–300 mcgHow often: 2–3× dailyHalf-life ~30 min●●●
  • GHRP-6Growth Hormone Releasing Peptide-6Studied range: 100–300 mcgHow often: 2–3× dailyHalf-life ~20 min●●●
  • HexarelinExamorelinStudied range: 100–200 mcgHow often: 2–3× dailyHalf-life ~55–70 min●●●
  • HGHGH · rHGH · Human Growth Hormone · Growth Hormone · Somatropin · hGHStudied range: 1–4 IUHow often: DailyHalf-life ~3-4 hours●●●
  • IGF-1 LR3Long R3 IGF-1 · LR3 IGF-1 · LongR3-IGF-I · Long [Arg3] IGF-I · IGF1 LR3 · IGF-1 Long R3Studied range: 20–50 mcgHow often: DailyHalf-life: no figure●●●
  • IpamorelinIPAMStudied range: 200–300 mcgHow often: 2–3× dailyHalf-life ~2 hours●●●
  • MK-677Ibutamoren · Nutrobal · MK677 · Ibutamoren MesylateStudied range: 10–25 mgHow often: DailyHalf-life ~24 hours●●●
  • PEG-MGFMechano Growth Factor · MGF · PEGylated MGF · IGF-1Ec · IGF-1 Ec peptide · MGF E-peptideStudied range: 200–400 mcgHow often: 2–3× weeklyHalf-life: no figure●●●
  • SermorelinGHRH 1-29 · GRF 1-29Studied range: 200–500 mcgHow often: DailyHalf-life ~11–12 min●●●
  • TesamorelinEgriftaStudied range: 1–2 mgHow often: DailyHalf-life ~8–11 min●●●

Metabolic & GLP-115

  • 5-Amino-1MQ5-A-1MQ · 5Amino1MQ · 5-Amino-1-methylquinoliniumStudied range: 50–100 mgHow often: DailyHalf-life: no figure●●●
  • CagrilintideCagri · AM833 · NNC0174-0833Studied range: 0.25–2.4 mgHow often: WeeklyHalf-life ~1 week●●●
  • CagriSemaCagrilintide/semaglutide · Cagrilintide-semaglutide · Cagri-Sema · Cagri + SemaStudied range: 0.25–2.4 mgHow often: WeeklyHalf-life: no figure●●●
  • DulaglutideTrulicity · LY2189265 · DulaStudied range: 0.75–4.5 mgHow often: WeeklyHalf-life ~5 days●●●
  • LiraglutideVictoza · Saxenda · Liraglutide injectionStudied range: 0.6–3 mgHow often: DailyHalf-life ~13 hours●●●
  • MazdutideIBI362 · LY3305677 · XinermeiStudied range: 2–6 mgHow often: WeeklyHalf-life ~10 days●●●
  • OrforglipronFoundayo · LY3502970 · OrfoStudied range: 0.8–17.2 mgHow often: DailyHalf-life ~29–49 hours●●●
  • OxytocinOT · Love hormone · Oxytocin nasalStudied range: 10–40 IUHow often: 1–2× dailyHalf-life ~1–6 min●●●
  • PemvidutideALT-801Studied range: 1.2–2.4 mgHow often: WeeklyHalf-life: no figure●●●
  • RetatrutideLY3437943Studied range: 1–12 mgHow often: WeeklyHalf-life ~6 days●●●
  • SemaglutideOzempic · WegovyStudied range: 0.25–2.4 mgHow often: WeeklyHalf-life ~1 week●●●
  • Semaglutide (oral)Rybelsus · Wegovy pill · Ozempic pill · Oral semaglutideStudied range: 1.5–25 mgHow often: DailyHalf-life ~1 week●●●
  • SLU-PP-332SLU PP 332 · SLUPP332 · SLU-PP332Studied range: 250–1000 mcgHow often: DailyHalf-life: no figure●●●
  • SurvodutideBI 456906 · BI456906 · SurvoStudied range: 0.3–6 mgHow often: WeeklyHalf-life: no figure●●●
  • TirzepatideMounjaro · Zepbound · LY3298176Studied range: 2.5–15 mgHow often: WeeklyHalf-life ~5 days●●●

Longevity13

  • DSIPDelta Sleep-Inducing Peptide · Delta sleep peptideStudied range: 200–400 mcgHow often: DailyHalf-life: no figure●●●
  • EpitalonEpithalamin · Tetrapeptide AEDg · EpithalonStudied range: 5–10 mgHow often: DailyHalf-life: no figure●●●
  • FOXO4-DRIFOXO4-p53 DRI peptide · Senostatic peptideStudied range: 1–2 mgHow often: 3× weeklyHalf-life: no figure●●●
  • GlutathioneGSH · L-Glutathione · Reduced glutathione · Glutathione injectionStudied range: 100–600 mgHow often: DailyHalf-life ~14 min●●●
  • HumaninHN · Mitochondrial-derived peptideStudied range: 2–4 mgHow often: WeeklyHalf-life: no figure●●●
  • Klothoα-Klotho · Alpha Klotho · Klotho proteinStudied range: 0.01–0.1 mgHow often: WeeklyHalf-life: no figure●●●
  • MOTS-cMitochondrial Open Reading Frame of the 12S rRNA-cStudied range: 5–10 mgHow often: 2–3× weeklyHalf-life: no figure●●●
  • NAD+Nicotinamide adenine dinucleotide · NAD · NAD plusStudied range: 50–100 mgHow often: DailyHalf-life: no figure●●●
  • NMNNicotinamide Mononucleotide · Beta-NMN · NMN supplementStudied range: 250–1000 mgHow often: DailyHalf-life: no figure●●●
  • PinealonEDR peptide · Tripeptide-4 · Glu-Asp-ArgStudied range: 100–200 mcgHow often: DailyHalf-life: no figure●●●
  • SNAP-8Acetyl octapeptide-3 · Acetyl octapeptide-1 · Snap 8Studied range: 3–10%How often: 1–2× dailyHalf-life: no figure●●●
  • SS-31Elamipretide · Szeto-Schiller 31 · MTP-131Studied range: 2–4 mgHow often: DailyHalf-life: no figure●●●
  • VesugenKED peptide · Lys-Glu-Asp · VezugenStudied range: No reference doseHow often: DailyHalf-life: no figure●●●

Cognitive8

  • AdamaxStudied range: No reference doseHow often: DailyHalf-life: no figure●●●
  • CerebrolysinFPE 1070 · Cerebrolysin injectionStudied range: 5–10 mlHow often: DailyHalf-life: no figure●●●
  • DihexaPNB-0408 · N-hexanoic-Tyr-Ile-(6) aminohexanoic amideStudied range: 10–30 mgHow often: DailyHalf-life: no figure●●●
  • N-Acetyl Semax AmidateNA Semax Amidate · NASA peptide · Semax AmidateStudied range: 100–600 mcgHow often: DailyHalf-life: no figure●●●
  • NSI-189NSI189 · NSI 189 phosphateStudied range: 40–80 mgHow often: DailyHalf-life ~17–20 hours●●●
  • P21CNTF analog · P-21 peptideStudied range: 100–300 mcgHow often: DailyHalf-life: no figure●●●
  • SelankTuftsin analogue · TP-7Studied range: 250–500 mcgHow often: DailyHalf-life ~10 min in blood●●●
  • SemaxACTH 4-7 Pro8Gly9Pro10 · N-acetyl SemaxStudied range: 200–900 mcgHow often: DailyHalf-life: no figure●●●

Sexual health6

  • EnclomipheneAndroxal · Trans-clomiphene · Enclomiphene citrateStudied range: 12.5–25 mgHow often: DailyHalf-life ~10 hours●●●
  • GonadorelinGnRH · Gonadotropin-releasing hormone · Gonadorelin acetateStudied range: 100 mcgHow often: 2–3× weeklyHalf-life ~2–10 min●●●
  • Kisspeptin-10KP-10 · Kisspeptin · Metastin fragmentStudied range: 50–500 mcgHow often: 2–3× weeklyHalf-life ~4 min●●●
  • Melanotan IMT-1 · MT1 · Melanotan 1 · Afamelanotide · Scenesse · CUV1647 · NDP-MSHStudied range: 250–1000 mcgHow often: DailyHalf-life ~0.8–1.7 hours●●●
  • Melanotan IIMT-2 · MT2 · Melanotan 2Studied range: 250–500 mcgHow often: DailyHalf-life: no figure●●●
  • PT-141Bremelanotide · PT141 · VyleesiStudied range: 0.5–2 mgHow often: As neededHalf-life ~2.7 hours●●●

PepVault for iPhone

Track any of these in PepVault

Log doses, manage your vials, plan titrations, and watch your protocol come together. 7 days free on the yearly plan for new subscribers.

Download on the App Store